| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 08/05/2009 | CN101501070A Antigenic GM-CSF peptides and antibodies to GM-CSF |
| 08/05/2009 | CN101500598A Cladribine regimen for treating multiple sclerosis |
| 08/05/2009 | CN101500547A Use of glucocorticoid receptor antagonists for treatment of infectious conditions |
| 08/05/2009 | CN101498731A Human monoclonal antibody against a costimulatory signal transduction molecule ATLIM and pharmaceutical use thereof |
| 08/05/2009 | CN101497581A Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof |
| 08/05/2009 | CN101496902A Allergen protecting agent |
| 08/05/2009 | CN101496901A Application of acidic buffer in stable pollen allergen activity |
| 08/05/2009 | CN101496887A Medicament for treating acute hot, itching and wet severe type and chronic urticaria |
| 08/05/2009 | CN101496819A Eubacterium, Clostridium preparation and use thereof |
| 08/05/2009 | CN101496814A Application of mesenchymal stem cell in preparing medicament for inhibiting chronic rejection after blood vessel transplantation |
| 08/05/2009 | CN101496603A Health-care food with enhancing immunity and antioxidation functions |
| 08/05/2009 | CN100523215C RNA interference mediating small RNA molecules |
| 08/05/2009 | CN100523212C Process for producing tripeptides |
| 08/05/2009 | CN100523192C Vaccines from infectious agents |
| 08/05/2009 | CN100523189C Function and use of human immune cell inhibition acceptor KLRL1 |
| 08/05/2009 | CN100523176C Transplant acceptance inducing cells of monocytic origin and their preparation and use |
| 08/05/2009 | CN100522995C Cell wall acyl-alanyl-D-isoglutamine derivative and its preparation, medicine composition and use |
| 08/05/2009 | CN100522983C Medical use of catalpol and its homologs |
| 08/05/2009 | CN100522969C Process for producing flavone C glycoside derivatives |
| 08/05/2009 | CN100522967C Phosphorus-containing compounds & uses thereof |
| 08/05/2009 | CN100522955C Cytotoxic agents containing novel potent taxanes and their therapeutic use |
| 08/05/2009 | CN100522944C Carboxylic acid derivative and thereof |
| 08/05/2009 | CN100522943C Vitamin d analogues |
| 08/05/2009 | CN100522921C Novel antihistaminic piperidine derivatives and intermediates for the preparation thereof |
| 08/05/2009 | CN100522242C Artificial proteins with reduced immunogenicity |
| 08/05/2009 | CN100522229C Health-care potables and its preparing method |
| 08/05/2009 | CN100522199C Externally applied medicine for treating dermatosis |
| 08/05/2009 | CN100522166C (1-4-piperidinyl) benzimidazole derivatives useful as histamine H3 antagonists |
| 08/04/2009 | US7569666 Polypeptides associated with activatory receptors and their biological applications |
| 08/04/2009 | US7569663 Genetically engineered fusion proteins for use in diagnosis and treatment of cancer, viral infections, autoimmune and alloimmune diseases |
| 08/04/2009 | US7569585 Drugs; analgesics; anesthetics; antiarrhythmia agents; antiinflammatory agents ; incontinence; gastrointestinal disorders; neurodegenerative disease |
| 08/04/2009 | US7569569 Pyrrolo[2,3-d]pyrimidine compounds |
| 08/04/2009 | US7569567 3-Heteroaryl-3,5-dihydro-4-oxo-4H-pyridazino[4,5-B]indole-1-carboxamide derivatives, their preparation and therapeutic use |
| 08/04/2009 | US7569561 For treating carcinoma chosen from cervical, breast, colon, head and neck, lung, pancreas, prostate, sarcomas, leukaemias, lymphomas, melanomas and gliomas |
| 08/04/2009 | US7569387 Specifically binds an MK61 polypeptide produced by immunizing an animal |
| 08/04/2009 | US7569218 Compositions for and methods of using herpes simplex virus glycoprotein D to suppress immune responses |
| 08/04/2009 | US7569212 Impregnation of contact lenses in a solution which comprises one or more suitable components for the treatment, care and/or protection of the eye |
| 08/04/2009 | CA2433785C Pharmaceutical compositions which inhibit vascular proliferation and method of use thereof |
| 08/04/2009 | CA2365281C Human antibodies that bind human il-12 and methods for producing |
| 08/04/2009 | CA2320959C Cytokine inducers comprising m161ag |
| 08/04/2009 | CA2247009C Cryptic peptides and method for their identification |
| 08/04/2009 | CA2207850C Use of mono and bicarboxylic acid amides for the manufacture of a medicament active at the peripheral cannabinoid receptor |
| 08/04/2009 | CA2194673C A conjugate between a modified superantigen and a target-seeking compound and the use of the conjugate |
| 07/30/2009 | WO2009094169A1 Cyclic carbazate and semicarbazide inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
| 07/30/2009 | WO2009094168A1 Cxcr3 antagonists |
| 07/30/2009 | WO2009093900A1 Mid-log phase lactic acid bacteria for inducing immune tolerance in a subject |
| 07/30/2009 | WO2009093533A1 IgE ANTIBODY PRODUCTION INHIBITOR |
| 07/30/2009 | WO2009093049A1 Fused pyridines active as inhibitors of c-met |
| 07/30/2009 | WO2009092764A1 Compounds comprising a cyclobutoxy group |
| 07/30/2009 | WO2009092284A1 Benzocycloheptene derivatives, preparing processes and pharmaceutical uses thereof |
| 07/30/2009 | WO2009071892A3 Method for the detection of dead and dying cells |
| 07/30/2009 | WO2009064854A3 Humanized antibodies against tl1a |
| 07/30/2009 | WO2009043464A3 Astressin and beta- endorphin for use as therapeutic agents |
| 07/30/2009 | WO2009043451A3 Use of chorionic gonadotropin-beta (109-145) as a therapeutic agent |
| 07/30/2009 | WO2009043450A3 Use of neurotrophic factor for retinal cholinergic neurons (nfrcn) and chorionic gonadotropin-beta (109-145) as therapeutic agents |
| 07/30/2009 | WO2009043449A3 Use of a peptide as a therapeutic agent |
| 07/30/2009 | WO2009043447A3 Use of a peptide as a therapeutic agent |
| 07/30/2009 | WO2009040004A3 Use of a peptide as a therapeutic agent |
| 07/30/2009 | WO2009033813A3 Use of a peptide as a therapeutic agent |
| 07/30/2009 | WO2009033774A3 Use of a laminin nonapeptide as a therapeutic agent |
| 07/30/2009 | WO2009033769A3 Use of cortistatin 14 and others as a therapeutic agent |
| 07/30/2009 | WO2009033722A8 Use of a octreotide as a therapeutic agent |
| 07/30/2009 | WO2008145754A3 Ligands of hvem for treating hematologic malignancies and autoimmune diseases |
| 07/30/2009 | WO2008127975A3 Use of an inhibitor of tnfa plus an antihistamine to treat allergic rhinitis and allergic conjunctivitis |
| 07/30/2009 | US20090192292 Murine zcytor17 ligand polypeptides and polynucleotides |
| 07/30/2009 | US20090192195 Compounds Having CRTH2 Antagonist Activity |
| 07/30/2009 | US20090192177 2-ARYL pyrrologpyrimidines for A1 and A3 receptors |
| 07/30/2009 | US20090192153 Novel adenine compound |
| 07/30/2009 | US20090192129 Bicyclic pyrrole derivatives |
| 07/30/2009 | US20090192105 RNA INTERFERENCE MEDIATED INHIBITION OF INTERCELLULAR ADHESION MOLECULE (ICAM) GENE EXPRESSION USING SHORT INTERFERING NUCELIC ACID (siNA) |
| 07/30/2009 | US20090192081 Casein derived peptides and uses thereof |
| 07/30/2009 | US20090192071 Use of photodynamic therapy to enhance treatment with immuno-modulating agents |
| 07/30/2009 | US20090191253 Use of K-252a and Kinase Inhibitors for the Prevention or Treatment of HMGB1-Associated Pathologies |
| 07/30/2009 | US20090191241 Method and compositions for immunization with the pseudomonas v antigen |
| 07/30/2009 | US20090191239 Recombinant infectious laryngotracheitis virus and uses thereof |
| 07/30/2009 | US20090191237 Methods and reagents for vaccination which generate A CD8 T cell immune response |
| 07/30/2009 | US20090191229 Adjuvancy and immune potentiating properties of natural products of onchocerca volvulus |
| 07/30/2009 | US20090191228 Immunogenic compositions capable of activating T-cells |
| 07/30/2009 | US20090191227 Compositions and Methods for Enhancing Immune Responses to Vaccines |
| 07/30/2009 | US20090191226 Adjuvant formulation comprising a submicron oil droplet emulsion |
| 07/30/2009 | US20090191214 Anti-human il-21 monoclonal antibodies |
| 07/30/2009 | US20090191200 Method for the Treatment of Multiple Sclerosis by Inhibiting IL-17 Activity |
| 07/30/2009 | US20090191188 Immunostimulatory nucleic acids |
| 07/30/2009 | US20090191174 Blood processing device and associated systems and methods |
| 07/30/2009 | US20090191164 Human hematopoietic multipotent progenitor cells |
| 07/30/2009 | US20090191149 IL-1alpha IMMUNIZATION INDUCES AUTOANTIBODIES PROTECTIVE AGAINST ATHEROSCLEROSIS |
| 07/30/2009 | US20090191147 Use of Interleukin-11 to Prevent Immune-Mediated Cytotoxicity |
| 07/30/2009 | US20090191144 Use of lipid components against pollen allergies |
| 07/30/2009 | US20090191136 Use of active substance complexes of panthenol, glycerol, citrate and/or bisabolol against pollen allergies |
| 07/30/2009 | US20090191117 Anti-Integrin Antibodies, Compositions, Methods and Uses |
| 07/30/2009 | DE19549794B4 Microemulsion pre-concentrate of active agent with low solubility - with carrier medium comprising hydrophilic phase contg. di-methyl-isosorbide and/or alkanoic ester, lipophilic phase and surfactant |
| 07/30/2009 | DE102008006394A1 Verwendung von Wirkstoffkomplexen aus Panthenol, Glycerin, Citrat und/oder Bisabolol gegen Pollenallergien Use of active complexes of panthenol, glycerin, citrate and / or bisabolol to pollen allergies |
| 07/30/2009 | CA2712791A1 Fused pyridines active as inhibitors of c-met |
| 07/30/2009 | CA2712604A1 Iap inhibitors |
| 07/30/2009 | CA2712500A1 Cyclic carbazate and semicarbazide inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
| 07/30/2009 | CA2710474A1 Compounds comprising a cyclobutoxy group |
| 07/29/2009 | EP2083076A1 In vitro differentiation/induction of lymphocyte from stem cell having genotype provided after gene reconstitution |
| 07/29/2009 | EP2083014A2 Inhibitors of interleukin-1ß converting enzyme |
| 07/29/2009 | EP2083011A1 Pyrroline derivatives against cell releasing tumor necrosis factor, preparation methods and uses thereof |
| 07/29/2009 | EP2082749A2 Prevention and treatment of Alzheimer's disease |